Matinas BioPharma Holdings's top three insider shareholders as of June 18, 2026 are Herbert J Conrad (Director, 4.20Mn shares), Raphael J Mannino (Chief Scientific Officer, 1.92Mn shares), Matthew Wikler (Director, 290.47K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Matthew Wikler | - | 290,472 | 0 | 03 Jan, 2022 |
| Raphael J Mannino | Chief Scientific Officer | 1,919,715 | 0 | 14 Sep, 2021 |
| Herbert J Conrad | - | 0 | 4,199,944 | 09 Jul, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Apr, 2025 | Robin L Smith | Stock Option (right to Buy) | A | 11,600 | $0.00 | 11,600 | D | A |
| 30 Apr, 2025 | Edward Neugeboren | Stock Option (right to Buy) | A | 11,600 | $0.00 | 11,600 | D | A |
| 30 Apr, 2025 | Edward Neugeboren | Stock Option (right to Buy) | A | 11,600 | $0.00 | 11,600 | D | A |
| 30 Apr, 2025 | An Evelyn D | Stock Option (right to Buy) | A | 11,600 | $0.00 | 11,600 | D | A |
| 30 Apr, 2025 | Jerome D Jabbour | Stock Option (right to Buy) | A | 70,100 | $0.00 | 70,100 | D | A |
| 15 Dec, 2023 | Thomas Hoover | Stock Option (right to Buy) | A | 1,000,000 | $0.00 | 1,000,000 | D | A |
| 15 Dec, 2023 | Theresa Matkovits | Stock Option (right to Buy) | A | 1,300,000 | $0.00 | 1,300,000 | D | A |
| 15 Dec, 2023 | James J. Iii Ferguson | Stock Option (right to Buy) | A | 1,200,000 | $0.00 | 1,200,000 | D | A |
| 15 Dec, 2023 | Jerome D Jabbour | Stock Option (right to Buy) | A | 3,500,000 | $0.00 | 3,500,000 | D | A |
| 15 Dec, 2023 | Hui Liu | Stock Option (right to Buy) | A | 1,000,000 | $0.00 | 1,000,000 | D | A |
| 15 Dec, 2023 | Theresa Matkovits | Stock Option (right to Buy) | A | 1,300,000 | $0.00 | 1,300,000 | D | A |
| 15 Dec, 2023 | Keith A Kucinski | Stock Option (right to Buy) | A | 1,000,000 | $0.00 | 1,000,000 | D | A |
| 01 Nov, 2023 | James S Scibetta | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |
| 01 Nov, 2023 | Matthew Wikler | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |
| 01 Nov, 2023 | Eric J Ende | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |
| 01 Nov, 2023 | Natasha Giordano | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |
| 01 Nov, 2023 | Matthew Wikler | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |
| 01 Nov, 2023 | James S Scibetta | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |
| 01 Nov, 2023 | Kathryn Penkus Corzo | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |
| 01 Nov, 2023 | Herbert J Conrad | Stock option (right to buy) | A | 437,244 | $0.00 | 437,244 | D | A |